Fact Source: Financial Supervisory Service DART
💡 3-Second Summary
Celltrion announced the additional listing of 57,364 new common shares on November 13, 2024, issued following the exercise of stock options.
📊 [Key Disclosure Details & Financial Highlights]
- Additional Listing Overview
- Type and Number of Shares: Registered Common Stock 57,364 shares
- Method of Capital Increase: Exercise of Stock Options
- Issue Date: October 24, 2024
- Listing Date: November 13, 2024
- Dividend Accrual Date: January 01, 2024 (Fiscal Year-End: December 31)
- Issue Price Per Share and Quantity by Tranche
- Tranche 142: KRW 52,697 (400 shares)
- Tranche 143: KRW 86,161 (5,863 shares)
- Tranche 144: KRW 78,213 (12,951 shares)
- Tranche 145: KRW 169,828 (4,831 shares)
- Tranche 146: KRW 170,330 (3,879 shares)
- Tranche 147: KRW 49,499 (16,800 shares)
- Tranche 148: KRW 134,308 (9,140 shares)
- Tranche 149: KRW 140,017 (3,500 shares)
- Stock & Industry Codes
- Standard Code: KR7068270008 (Short Code: 068270)
- Industry Code: 03-21-01
📝 Editor’s Comment (Key Follow-up Checkpoint)
📌 Verification of Total Issued Shares and Stock Quantity Changes Post-Listing
This disclosure reports the additional listing of new shares resulting from the exercise of stock options. Tracking the total number of issued shares after the listing is important for accurately understanding changes in the company’s capital structure. Detailed information can be verified under the “Total Number of Shares” section in the upcoming periodic disclosure (Quarterly or Annual Report).
📢 Disclaimer & Source Notice
Source: This content has been newly structured and created based on official submission data from the Financial Supervisory Service’s Data Analysis, Retrieval and Transfer System (DART).
Investment Risk Warning: This content is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest solely with the investor.
Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.
